Mirabegron CAS 223673-61-8 CAS NO.223673-61-8

FOB Price:: USD 95.00-100.00 /Gram Get Latest Price

Min.Order Quantity:: 1 Gram

Purity:: 99%

Port:: tianjin/qingdao/shanghai

Payment Terms:: T/T,MoneyGram

Add to Inquiry Cart

Product Details

Keywords

Mirabegron
CAS 223673-61-8
223673-61-8

Quick Details

ProName: Mirabegron CAS 223673-61-8
CasNo: 223673-61-8
Molecular Formula: C21H24N4O2S
Appearance: white powder
Application: Animal Pharmaceuticals
DeliveryTime: within 2-3 day
PackAge: carton boc
Port: tianjin/qingdao/shanghai
ProductionCapacity: 1000000 Kilogram/Month
Purity: 99%
Storage: cool and dry
Transportation: ship,fly
LimitNum: 1 Gram
Heavy metal: 1
Grade: Industrial Grade
1: 100

Superiority

hebei mojin biotechnology co., ltd,our business covers more than 30 countries, most of the big customers come from europe, america and other countries in the world, we can guarantee the quality and price. in recent decades, with the efforts of all employees, we have established many cooperative companies in shandong, henan, guangdong and other places. our corporate purpose is based on the market, enhance the strength, take the road of scientific and environmental sustainable development, relying on the country. technology r & d center, increase the investment in r & d, based on the domestic market, expand the international market, manufacturing quality products, sincere service to the society, into a modern, ecological, scientific and technological enterprise world.

adenosine triphosphate can be used in the disease caused by tissue injury and activity reduction of ecto enzyme , including heart failure, carditis, miocardial infarction, cerebral arteriosclersis, coronary sclerosis, progressive muscular atrophy , cerebral hemorrhage , chronic hepatitis, cirrhosis of liver and hearing handicap, etc.

Details

product detailed

product name:	mirabegron
synonyms:	2-amino-n-[4-[2-[[(2r)-2-hydroxy-2-phenyl-ethyl]amino]-ethyl]phenyl]-4-thiazoleacetamide;2-(2-amino-1,3-thiazol-4-yl)-n-(4-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}phenyl)acetamide;(2r)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide;4-thiazoleacetamide, 2-amino-n-(4-(2-(((2r)-2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)-;mirabegron;n-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide;ym 178;mirabegron(ym 178)
cas:	223673-61-8
mf:	c21h24n4o2s
mw:	396.51
einecs:	800-126-3
product categories:	amines;aromatics;heterocycles;intermediates & fine chemicals;pharmaceuticals;sulfur & sele nium compounds

betanis (mirabegron) was approved in july 2011 by the japanese ministry of health, labour, and welfare for the treatment of urgency, urinary frequency, and urinary urge urinary incontinence associated with overactive bladder (oab). mirabegron is synthesized by coupling 4-nitrophenethyl amine to (r)-2-hydroxy-2-phenylacetic acid. the resulting amide is reduced to an amine. the nitro group is then reduced and the resulting anil ine is coupled to 2-(2-aminothiazol-4-yl) acetic acid to give mirabegron. mirabegron has an ec50 of 22 nm (intrinsic activity=0.8) for β3-ar with no detectable activity for β1- andβ2-ar (ec50>10,000 nm). in an anesthetized rat rhythmic bladder contraction model in which bladder contractions are induced by saline, mirabegron at 3 mg/kg iv decreased the frequency of rhythmic bladder contraction without suppressing contraction amplitude. these data suggest that the activation of β3-ar increases bladder capacity without influencing the frequency of bladder contraction.